Koers GlobeImmune Inc Other OTC
Aandelen
US37957B1008
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 5,97 mln. 5,49 mln. | Omzet 2015 | 6,46 mln. 5,95 mln. | Marktkapitalisatie | 22,26 mln. 20,5 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -16 mln. -14,74 mln. | Nettowinst (verlies) 2015 | -2 mln. -1,84 mln. | EV/omzet 2014 | 4,5 x |
Nettoliquiditeiten 2014 | 16,81 mln. 15,48 mln. | Nettoliquiditeiten 2015 | 9,9 mln. 9,12 mln. | EV/omzet 2015 | 1,91 x |
K/w-verhouding 2014 |
-0,94
x | K/w-verhouding 2015 |
-8,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Augustine Lawlor
BRD | Director/Board Member | 67 | 01-06-03 |
Ehud Geller
BRD | Director/Board Member | 77 | - |
Charles C. Kim
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,30% | 118 mld. | |
+12,15% | 106 mld. | |
-8,14% | 23,4 mld. | |
-0,29% | 21,78 mld. | |
-9,28% | 18,09 mld. | |
-41,70% | 16,72 mld. | |
-15,33% | 15,97 mld. | |
+5,80% | 14,03 mld. | |
+28,03% | 11,67 mld. |